Leukemia cells of patients with high-risk disease and RT express high amounts of activated phosphorylated AKT and a phenotype resembling RT resulted from constitutive activation of AKT in the Eμ-TCL1 CLL mouse model (59). Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.